Optain Health has made a significant move in healthcare technology by acquiring EyePACS, a leader in U.S. teleophthalmology. This partnership is set to revolutionize early disease detection using advanced retinal imaging. As these organizations join forces, patients and clinicians can expect expanded access to innovative screening tools both in the U.S. and globally.
Optain Health and EyePACS Unite to Advance Retinal Imaging
With the acquisition of EyePACS, Optain Health is combining its next-generation robotic retinal imaging with a nationwide teleophthalmology network. EyePACS has supported community-based screening for over twenty years, helping to identify severe sight-threatening diseases across more than 1.5 million patients. Through this union, both companies aim to deliver enhanced retinal screening directly within primary care settings.
Innovative Robotic Imaging and Teleophthalmology Integration
One of the partnership’s biggest advantages is the integration of AI-powered imaging and teleophthalmology. Optain Health’s technology allows for rapid, high-quality images without the need for dilation or specialized operators. Key features of the unified platform include:
- Push-button robotic imaging with no dilation necessary
- Lightweight, portable cameras for point-of-care use
- Multilingual patient guidance for greater accessibility
- Diagnostic grading for diabetic retinopathy and other conditions
- Seamless electronic health record (EHR) integration
- Scalable analytics for population health programs
This integrated approach better supports clinics, care teams, and diverse patient populations.
Expanding Access and Future Investment in Preventive Eye Care
The newly formed alliance will not disrupt EyePACS’s operations for clinics already using its platform. Optain Health plans substantial investments to further develop both systems, broadening reach and boosting efficiency. Already live at more than 200 sites worldwide—with over 1,000 more in the planning stage—Optain Health will now help advance preventive eye care for more patients throughout the U.S. and globally.
In summary, Optain Health’s acquisition of EyePACS stands to transform preventive eye health. By combining cutting-edge technology with a broad, established network, the partnership brings advanced retinal screening to the frontlines of care. Ultimately, this collaboration promises to close critical healthcare gaps and improve outcomes for millions worldwide.
Don’t miss our latest Startup News: FPT AI Notebook Empowers Developers With Faster, Smarter AI Innovation
